Suven Pharmaceuticals Ltd.’s (COHANCE) Moving Averages Convergence Divergence (MACD) indicator is -0.66, suggesting Suven Pharmaceuticals Ltd. is a Buy.
Suven Pharmaceuticals Ltd.’s (COHANCE) 20-Day exponential moving average is 452.82, while Suven Pharmaceuticals Ltd.’s (COHANCE) share price is ₹464.55, making it a Buy.
Suven Pharmaceuticals Ltd.’s (COHANCE) 50-Day exponential moving average is 450.99, while Suven Pharmaceuticals Ltd.’s (COHANCE) share price is ₹464.55, making it a Buy.
Suven Pharmaceuticals Ltd.’s (COHANCE) 10-Day exponential moving average is 451.72, while Suven Pharmaceuticals Ltd.’s (COHANCE) share price is ₹464.55, making it a Buy.
Suven Pharmaceuticals Ltd.’s (COHANCE) 100-Day exponential moving average is 446.64, while Suven Pharmaceuticals Ltd.’s (COHANCE) share price is ₹464.55, making it a Buy.
Suven Pharmaceuticals Ltd.’s (COHANCE) stock price is ₹464.55 and Suven Pharmaceuticals Ltd.’s (COHANCE) 50-day simple moving average is 451.75, creating a Buy signal.
Suven Pharmaceuticals Ltd.’s (COHANCE) stock price is ₹464.55 and Suven Pharmaceuticals Ltd.’s (COHANCE) 100-day simple moving average is 446.97, creating a Buy signal.
Suven Pharmaceuticals Ltd.’s (COHANCE) stock price is ₹464.55 and Suven Pharmaceuticals Ltd.’s (COHANCE) 200-day simple moving average is 409.67, creating a Buy signal.